PMID: 18206277DOI: 10.1016/j.vaccine.2007.12.011Jan 22, 2008Paper
The demand for a dengue vaccine: a contingent valuation survey in Metro Manila
Vaccine
Rosalina Palanca-Tan
Abstract
Using data gathered from a contingent valuation survey, this study estimated the willingness to pay (WTP) for a single dengue fever vaccine and the household demand function for dengue vaccines. Mean WTP for the vaccine ranged from US$27 to US$32 and household demand averaged 2 per household. Our findings indicate sufficiently high WTP for dengue vaccines and hence a significant potential for selling the vaccine in private markets. For the lower income groups with lower capacity to pay, a mass vaccination campaign program in which part of the financial costs are covered by vaccine user charges is viable.
References
Nov 8, 2003·Vaccine·Denise DeRoeckJohn D Clemens
Jan 16, 2004·Health Economics·Henrik Hammar, Olof Johansson-Stenman
Sep 24, 2004·Health Economics·Jin-Tan LiuMeng-Wen Tsou
Apr 4, 2006·Health Policy and Planning·Gia Canh DoCamilo Acosta
❮ Previous
Next ❯
Citations
Mar 3, 2011·The American Journal of Tropical Medicine and Hygiene·Mark E BeattyJoel N Kuritsky
Oct 30, 2013·ACS Chemical Biology·Muslum YildizJeanne A Hardy
Oct 18, 2012·BMC Public Health·Rohan DeogaonkarMark Jit
Aug 20, 2014·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Adrienne F G Alayli-GoebbelsJohan L Severens
Dec 8, 2015·Expert Review of Vaccines·Yesim Tozan
Jan 2, 2010·Vaccine·Derek S BrownMark L Messonnier
Nov 13, 2012·Vaccine·Sachiko OzawaOrin S Levine
Dec 12, 2012·Tropical Medicine & International Health : TM & IH·Thanittha DitsuwanSuwich Thammapalo
Sep 4, 2015·BMC Medicine·Mark JitJoanne Yoong
Feb 4, 2014·Vaccine·Chen-Yi ChiangHsin-Wei Chen
Oct 12, 2010·Human Vaccines·Ananda AmarasingheRichard T Mahoney
Dec 8, 2015·PloS One·Daniel Slunge
May 24, 2014·PLoS Neglected Tropical Diseases·Li Ping WongKaruthan Chinna
Nov 6, 2014·PloS One·Yuan DongJianqing Xu
Dec 3, 2016·Human Vaccines & Immunotherapeutics·Harapan HarapanUlrich Kuch
Dec 3, 2016·Acta Tropica·Harapan HarapanSetia Pramana
Aug 29, 2018·The Pediatric Infectious Disease Journal·Daniel OlsonEdwin J Asturias
Nov 24, 2018·Expert Review of Pharmacoeconomics & Outcomes Research·Roberto Lúcio Muniz JúniorCristina Mariano Ruas
Nov 28, 2018·Cost Effectiveness and Resource Allocation : C/E·Hui Yee Yeo, Asrul Akmal Shafie
May 1, 2020·PloS One·Abdur Razzaque SarkerJahangir A M Khan
Apr 26, 2019·PLoS Neglected Tropical Diseases·Kristal An AgrupisJacqueline Deen
Aug 22, 2020·Human Vaccines & Immunotherapeutics·K M Ariful KabirJun Tanimoto
Sep 30, 2020·Human Vaccines & Immunotherapeutics·Harapan HarapanMudatsir Mudatsir
Sep 27, 2013·PLoS Neglected Tropical Diseases·Panji Fortuna Hadisoemarto, Marcia C Castro
Apr 10, 2019·PloS One·Yogambigai RajamoorthyHarapan Harapan
May 17, 2017·Annals of Clinical Microbiology and Antimicrobials·Yalil T Bracho-ChurioFredi A Diaz-Quijano
Jun 2, 2015·PLoS Neglected Tropical Diseases·Jung-Seok LeeBrian A Maskery
Dec 10, 2019·Expert Review of Pharmacoeconomics & Outcomes Research·Túlio Tadeu Rocha SarmentoCristina Mariano Ruas
Mar 31, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Nicholas W S ChewVijay K Sharma
Apr 15, 2021·Journal of Comparative Effectiveness Research·Thannuse Silva AthieIsabella Piassi Dias Godói
May 1, 2021·Vaccines·Serkan Catma, Serkan Varol
May 1, 2021·Human Vaccines & Immunotherapeutics·Serkan Catma, Diana Reindl
May 5, 2021·PloS One·Wen QinZhengyu Ni
❮ Previous
Next ❯
Related Concepts
Related Feeds
Related Papers
Vaccine
Marcelino E S LucasDale Whittington
Health Policy
Ziaul IslamDale Whittington
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Dale WhittingtonViroj Tangcharoensathien
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Dohyeong KimDale Whittington
Vaccine
Dale WhittingtonSubhrendu Pattanayak